@prefix np: . @prefix npx: . @prefix ns1: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { rdf:OBJECT rdfs:label "data" . rdf:OBJECT-POSITION rdfs:label "(0, 13)" . rdf:PREDICATE rdfs:label "encouraging" . rdf:PREDICATE-POSITION rdfs:label "37" . rdf:SUBJECT rdfs:label "Dexamethasone and tocilizumab showed" . rdf:SUBJECT-POSITION rdfs:label "(0, 13)" . ns1:encourage ; rdfs:label "dexamethasone" . rdfs:label "data" . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4" . sub:assertion prov:generatedAtTime "2023-06-01T14:26:59.025381"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4692-1377 . rdf:Statement rdfs:label "Dexamethasone and tocilizumab showed encouraging data, but Dexamethasone and tocilizumab's use needs to be further validated." . rdfs:ABSTRACT-UID rdfs:label "fp4chn9a" . rdfs:TRIPLE-UID rdfs:label "fp4chn9a-TRIPLE-ABSTRACT-2" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "avRpe+PvJD+H47Nr4qGP5s/KKHYBCC2CdwgOzBIDHM9tqzX/Ow/7+EnmyZ3x6cPO0flo7BN/J8dnX96i/dvM+DSyzVnWqE9gV7/EgU1BNbMIsYZnjEaQpKYhNrY4/sGUyE1MCBVnGC1xWgKxzTOFpFJeCFJoz13dlDS7vIlk5SFX06dVxUJsZhKKp671o4hi+Z5s3KOfcfJ1Ef8OJhJu7LqfqIrnWKZWD3sAkgu/3I4q6+KU/cu6OfKOf8gLb8AqC4Vi4OZzxSk7t38zaKrTuX6gfndx133L3Bac5B9D/1aMKqfQOqaoir56BaBHi7FH+tumAkTuqMsCsrB7rVBhTOqA14BC0rLaXmDhxthUEs1jKjFj+mcMsdC0Zjo7iGAztyT91+uiC/uEKetfaPwC0zq0DGywz9CZzJQLhMHiJjBP6TM9BIqFmW4bewLeYVIPVVpX/Jzg7iHwPO5bUZ8uCYLLZKIWL00ydmG5acsL3jvXHW+k/t0LAap7XM6OkijH"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }